Internal Medicine, Cardiovascular Disease · San Jose, CA
NPI
1639351125
Since 2007
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
969 Story Rd, Suite 6066
San Jose, CA, 95122
Phone (408) 293-5900
Groups this clinician bills Medicare through
Medicare paid, 2024
$802K
6,915 services
Medicare patients, 2024
1,120
Average age 77
Drug cost, 2024
$3.8M
29,295 prescriptions
Company payments, 2025
$12K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dan V Dang was code 99214 (office e&m - established), 2,663 times for 1,036 patients. In total Dan V Dang billed 6,915 services in 23 codes, and Medicare paid $802K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,663 | 1,036 | $120.57 | $321K |
| 99457 E&M - Miscellaneous | Office | 611 | 90 | $48.64 | $30K |
| 99454 E&M - Miscellaneous | Office | 599 | 88 | $52.77 | $32K |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 590 | 295 | $155.36 | $92K |
| 99458 E&M - Miscellaneous | Office | 449 | 80 | $37.80 | $17K |
| 93306 Echocardiography (TTE/TEE) | Office | 400 | 399 | $203.42 | $81K |
| 93015 Electrocardiogram | Office | 296 | 296 | $62.68 | $19K |
| 78452 Myocardial Perfusion Scan | Office | 295 | 295 | $465.44 | $137K |
| 93000 Electrocardiogram | Office | 200 | 200 | $13.63 | $2,726 |
| 99204 Office E&M - New | Office | 180 | 180 | $150.69 | $27K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 140 | 67 | $5.44 | $761 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 137 | 137 | $202.43 | $28K |
| 99453 E&M - Miscellaneous | Office | 83 | 83 | $21.93 | $1,820 |
| 93244 Electrocardiogram | Office | 74 | 73 | $20.51 | $1,518 |
| 93242 Electrocardiogram | Office | 74 | 73 | $13.19 | $976 |
By year: 2022 $573K for 4,098 services; 2023 $639K for 4,431 services; 2024 $802K for 6,915 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dan V Dang prescribed most often to Medicare patients was Carvedilol, with 5,634 prescriptions and refills. In total Dan V Dang wrote 29,295 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carvedilol Generic | 5,634 | 16,143 | 1,664 | $55K |
| Isosorbide Dinitrate Generic | 3,532 | 10,181 | 1,057 | $225K |
| Nitroglycerin Generic | 2,367 | 2,856 | 1,194 | $65K |
| Amlodipine Besylate Generic | 2,047 | 5,941 | 698 | $17K |
| Omega-3 Acid Ethyl Esters Generic | 1,725 | 4,840 | 684 | $92K |
| Pantoprazole Sodium Generic | 1,251 | 3,615 | 449 | $22K |
| Ranolazine Er Ranolazine | 1,200 | 3,394 | 357 | $140K |
| Losartan Potassium Generic | 1,015 | 2,911 | 352 | $13K |
| Vascepa Icosapent Ethyl | 1,008 | 1,693 | 299 | $482K |
| Clopidogrel Clopidogrel Bisulfate | 822 | 2,374 | 271 | $12K |
| Eliquis Apixaban | 689 | 1,148 | 158 | $660K |
| Icosapent Ethyl Generic | 595 | 1,157 | 228 | $193K |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 523 | 1,476 | 161 | $14K |
| Hydrochlorothiazide Generic | 502 | 1,160 | 152 | $1,728 |
| Montelukast Sodium Generic | 497 | 1,448 | 180 | $7,041 |
Brand drugs: - claims; generic drugs: 24,860 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dan V Dang $12K ($12K in general payments such as food, travel and fees) from 19 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $7,535.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 17 | $7,535 |
| Medtronic, Inc. MDT | 17 | $1,703 |
| Biotronik Inc. | 16 | $1,237 |
| Merck Sharp & Dohme LLC MRK | 8 | $244 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $221 |
| E.R. Squibb & Sons, L.L.C. BMY | 7 | $188 |
| Novo Nordisk Inc NVO | 6 | $135 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $125 |
| Amgen Inc. AMGN | 4 | $111 |
| Scpharmaceuticals Inc. SCPH | 3 | $78.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.